Synaptogenix Inc. (NASDAQ: SNPX)
$4.53
+0.1000 ( +2.26% ) 39.6K
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
Market Data
Open
$4.53
Previous close
$4.43
Volume
39.6K
Market cap
$5.45M
Day range
$4.41 - $4.64
52 week range
$3.53 - $24.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 53 | Nov 14, 2023 |
def | Proxies and info statements | 3 | Nov 13, 2023 |
8-k | 8K-related | 15 | Nov 06, 2023 |
pre | Proxies and info statements | 1 | Nov 03, 2023 |
8-k | 8K-related | 13 | Sep 22, 2023 |
10-q | Quarterly Reports | 54 | Aug 14, 2023 |
8-k | 8K-related | 13 | Jul 19, 2023 |